339 related articles for article (PubMed ID: 35372499)
1. Role of Globotriaosylceramide in Physiology and Pathology.
Celi AB; Goldstein J; Rosato-Siri MV; Pinto A
Front Mol Biosci; 2022; 9():813637. PubMed ID: 35372499
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
3. Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals.
Keusch JJ; Manzella SM; Nyame KA; Cummings RD; Baenziger JU
J Biol Chem; 2000 Aug; 275(33):25315-21. PubMed ID: 10854428
[TBL] [Abstract][Full Text] [Related]
4. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.
Puri A; Hug P; Jernigan K; Barchi J; Kim HY; Hamilton J; Wiels J; Murray GJ; Brady RO; Blumenthal R
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14435-40. PubMed ID: 9826718
[TBL] [Abstract][Full Text] [Related]
5. Global glycosphingolipid analysis in urine and plasma of female Fabry disease patients.
Heywood WE; Doykov I; Spiewak J; Hallqvist J; Mills K; Nowak A
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2726-2735. PubMed ID: 31319156
[TBL] [Abstract][Full Text] [Related]
6. Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells.
Kanda T; Ariga T; Kubodera H; Jin HL; Owada K; Kasama T; Yamawaki M; Mizusawa H
J Neurosci Res; 2004 Oct; 78(1):141-50. PubMed ID: 15372501
[TBL] [Abstract][Full Text] [Related]
7. Protein-glycosphingolipid interactions revealed using catch-and-release mass spectrometry.
Zhang Y; Liu L; Daneshfar R; Kitova EN; Li C; Jia F; Cairo CW; Klassen JS
Anal Chem; 2012 Sep; 84(18):7618-21. PubMed ID: 22920193
[TBL] [Abstract][Full Text] [Related]
8. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
9. Structural Diversities of Lectins Binding to the Glycosphingolipid Gb3.
Siukstaite L; Imberty A; Römer W
Front Mol Biosci; 2021; 8():704685. PubMed ID: 34381814
[TBL] [Abstract][Full Text] [Related]
10. The role of glycosphingolipids in HIV/AIDS.
Lingwood CA; Branch DR
Discov Med; 2011 Apr; 11(59):303-13. PubMed ID: 21524384
[TBL] [Abstract][Full Text] [Related]
11. Verotoxin Receptor-Based Pathology and Therapies.
Lingwood C
Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns.
Newburg DS; Chaturvedi P; Lopez EL; Devoto S; Fayad A; Cleary TG
J Infect Dis; 1993 Aug; 168(2):476-9. PubMed ID: 8335990
[TBL] [Abstract][Full Text] [Related]
13. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
[TBL] [Abstract][Full Text] [Related]
14. New aspects of the regulation of glycosphingolipid receptor function.
Lingwood CA; Manis A; Mahfoud R; Khan F; Binnington B; Mylvaganam M
Chem Phys Lipids; 2010 Jan; 163(1):27-35. PubMed ID: 19781539
[TBL] [Abstract][Full Text] [Related]
15. Neutral glycosphingolipid content of ovine milk.
Zancada L; Sánchez-Juanes F; Alonso JM; Hueso P
J Dairy Sci; 2010 Jan; 93(1):19-26. PubMed ID: 20059899
[TBL] [Abstract][Full Text] [Related]
16. Soluble adamantyl glycosphingolipid analogs as probes of glycosphingolipid function.
Lingwood C; Sadacharan S; Abul-Milh M; Mylvaganum M; Peter M
Methods Mol Biol; 2006; 347():305-20. PubMed ID: 17072019
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
18. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion.
Fantini J; Hammache D; Piéroni G; Yahi N
Glycoconj J; 2000; 17(3 -4):199-204. PubMed ID: 11201791
[TBL] [Abstract][Full Text] [Related]
19. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody.
Chark D; Nutikka A; Trusevych N; Kuzmina J; Lingwood C
Eur J Biochem; 2004 Jan; 271(2):405-17. PubMed ID: 14717708
[TBL] [Abstract][Full Text] [Related]
20. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer.
Kovbasnjuk O; Mourtazina R; Baibakov B; Wang T; Elowsky C; Choti MA; Kane A; Donowitz M
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19087-92. PubMed ID: 16365318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
